Navigation Links
Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History
Date:9/2/2009

Includes Allegations of Illicitly Promoting Antibiotic As Clinically Superior When Its Own FDA-Approved Label Said Otherwise; First-Ever Qui Tam Whistleblower Settlement of Its Type

PHILADELPHIA, Sept. 2 /PRNewswire-USNewswire/ -- Pfizer Inc. ignored a 2005 FDA Warning Letter to stop promoting its antibiotic Zyvox(R) as clinically superior to the significantly less expensive, generic vancomycin when its own FDA-approved label indicated otherwise. The drug giant also defrauded federal and state taxpayers by marketing Zyvox off-label, according to a qui tam whistleblower complaint filed by Philadelphia law firm Sheller, P.C. and other documents unsealed with today's $2.3 billion Pfizer settlement.

The $2.3 billion settlement included off-label marketing allegations for the withdrawn arthritis drug Bextra(R), which was included in the Sheller complaint. Zyvox (linezolid) is an antibacterial agent that is approved by the FDA to treat certain types of infections, including nosocomial pneumonia and complicated skin and skin structure infections ("CSSSIs") due to Methicillin Resistant Staphylococcus Aureus ("MRSA"). Worldwide sales of Zyvox totaled $1.115 billion in 2008.

The largest pharmaceutical qui tam whistleblower settlement in history, the $2.3 billion settlement was announced today by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts.

Stephen A. Sheller, Esq., named partner of the Philadelphia firm earlier this year, represented a relator, the legal term for a whistleblower, in the largest single-drug whistleblower case in U.S. history when Eli Lilly & Company paid $1.4 billion to settle Zyprexa(R) off-label marketing allegations. The Sheller firm's lawyers have previously represented several other whistleblowers in successful lawsuits.

Appr
'/>"/>

SOURCE Sheller, P.C. Law Firm
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Thelen Instrumental in Closing $1 Billion Outsourcing Deal for Client Harvard Pilgrim Health Care
2. Hospital infections cost $1 billion in lost bed days
3. MarketsandMarkets: Global Emerging Lighting Technologies Market Worth US$112.2 Billion by 2014
4. Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade
5. U.S. Compression Therapy Market to Reach $1.16 Billion in 2015, Finds Frost & Sullivan
6. MarketsandMarkets: Global Biomarker Market Worth US$ 20.5 Billion by 2014
7. Cardinal Health Announces $1.2 Billion Debt Tender Offer
8. MarketsandMarkets: Top Ten Medical Device Technologies Market Worth $454.3 Billion by 2014
9. New Study of House Health Reform Bill: California Faces Over $3.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
10. New Study of House Health Reform Bill: Minnesota Faces Over $654 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
11. New Study of House Health Care Reform Bill: Texas Faces Over $2.7 Billion in Medicare-Funded Nursing Home Cuts Over Ten Years
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 22, 2014 Setria® Glutathione is ... approved it for use “as a therapeutically active ... within the Therapeutic Goods (Listing) Notice 2014 (No. ... Hakko’s Setria® Glutathione will be exclusivity distributed in ... sources and imports fine chemicals to Australian manufacturers. ...
(Date:11/22/2014)... PITTSBURGH, PA (PRWEB) November 22, 2014 ... about the pain caused by the machine," said an ... injury, she had to go back a second time ... my invention idea." , She developed the patent-pending MAMO ... for breast cancer. The design saves the patient from ...
(Date:11/22/2014)... Lipitor lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that ... developed Type 2 diabetes due to its use continue ... underway in U.S. District Court, District of South Carolina, ... litigation will convene its next Status Conference on December ... Counsel for Plaintiffs and Defendants to meet and confer, ...
(Date:11/22/2014)... November 22, 2014 The Sports Conflict ... Roy Baroff to its team of conflict resolution professionals. ... player, coach, and referee. He has over 30 years experience ... beyond. , “I'm very excited to connect with SCI and ... related interests to a program with a complete sports focus,” ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 Wright & ... AndroGel side-effects lawsuits have been scheduled between October ... Northern District of Illinois. U.S. District Judge Matthew F. ... a Case Management Order (CMO) on November 6, 2014 ... for attorneys to submit documents and other activities in ...
Breaking Medicine News(10 mins):Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 2Health News:Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports 3Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 2Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 3Health News:First Bellwether Trials Scheduled In AndroGel Side-Effects Lawsuits Reports Wright & Schulte LLC 4
... The addition of zoledronic acid to adjuvant endocrine therapy ... disease recurrence among postmenopausal women with early hormone receptor-positive ... trial. Richard de Boer, M.D., of the ... from the Zometa-Femara Adjuvant Synergy Trial (ZO-FAST) trial at ...
... Treating ,brain tsunamis, or ,killer waves, could stop many victims ... study published in Lancet Neurology has found. ... the topic of spreading depolarizations now of keen interest to ... signature wound of the wars in Iraq and Afghanistan. ...
... - A majority of Americans professing belief in God ... the spread of nuclear weapons - branding it a ... conducted jointly by the University of Maryland,s Center for ... Program on International Policy Attitudes (PIPA). The nearly ...
... off a "genomic storm" in human immune cells, altering ... patterns. In a report to appear in the ... a nationwide research collaborative describe the initial results of ... injury, findings which have overturned some longstanding assumptions. ...
... with hormone receptor-positive metastatic breast cancer may have a ... to results of a study by the SWOG clinical ... San Antonio Breast Cancer Symposium. The combination of ... the SWOG S0226 trial extended the median survival time ...
... recognize the following scenario: Their favorite player scores a three-point ... ball. But does the fact that he scored the last ... it change the probability that he will score again? ... Neiman at the Hebrew University in Jerusalem shatters the myth ...
Cached Medicine News:Health News:Immediate bisphosphonate use with endocrine therapy reduced recurrence and increased survival in postmenopausal early breast cancer 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 2Health News:Brain tsunamis' are clue to helping victims of major head injuries 3Health News:US believers favor international action on climate change, nuclear risk: UMD poll 2Health News:US believers favor international action on climate change, nuclear risk: UMD poll 3Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 3Health News:Anti-estrogen combo better than single drug for hormone-sensitive breast cancer 2Health News:Heads up Kobe Bryant! Research shows that trying for another 3-pointer is a mistake 2
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
(Date:11/21/2014)... Nov. 21, 2014 In September 2014, the ... carried out a new product development plan that started ... "limited edition" lab coat , aptly named "Vera ... surgery in the world. The new women,s designer lab ... with a sleek envelope collar, vertical princess and high ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... HARRISBURG, Pa., Dec. 20, 2011  As part of a national ... care facilities with flu vaccination rates for staff of 90 ... www.flufreepa.com . "Increasing vaccination among health care ... and ensure the health of all Pennsylvanians," said Secretary of ...
... 20, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... marketer of medical devices worldwide, announced today an agreement ... Biotech Co., Ltd. ("TDR"). The terms of the agreement ... Mindray,s financial statements. Founded in 1997 and ...
Cached Medicine Technology:Pennsylvania Department of Health Lauds Health Care Facilities for Boosting Flu Vaccination Rates among Workforce 2Mindray Medical to Acquire a Controlling Stake in Hunan Changsha TDR Biotech 2Mindray Medical to Acquire a Controlling Stake in Hunan Changsha TDR Biotech 3
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
... The COLLEAGUE pumps can be customized ... range of care sites and therapies. The ... delivery sets to be used for both ... and excess costs. From simple infusions to ...
... Established in 1979, CRL ... services in the areas ... Insurance, Clinical Trials and ... one roof at our ...
Millenova Immunology Laboratories is a reference laboratory dedicated to the diagnosis of immunologic causes of reproductive failure, infertility and recurrent pregnancy loss....
Medicine Products: